Heart Failure

BMJ Uncovers Gaps in Ticagrelor Trial Integrity

The ONSET/OFFSET and RESPOND trials are under scrutiny for overstated efficacy, per the BMJ report.

Get With the Guidelines–Heart Failure: 20 Years in Review, Lessons Learned, and the Road Ahead

Izzah NawazHeart Failure | June 23, 2025

AHA’s GWTG-HF program marks 20 years, improving heart failure care at 600+ hospitals and highlighting ongoing care gaps.

FINEARTS-HF: Finerenone Benefit Remains Consistent Across Frailty Classes in Heart Failure

Lauren Dembeck, PhDHeart Failure | June 20, 2025

Finerenone cuts HF risk across all frailty classes, per FINEARTS-HF.

Broad Benefits of ATTR Therapy Seen Across Disease Spectrum

CardioNerdsHeart Failure | June 19, 2025

ATTR therapy shows consistent benefits across disease stages, including in patients with atrial fibrillation.

Advancements in Heart Failure Management: SGLT2 Inhibitors and Beyond

Pam BeilerHeart Failure | June 16, 2025

SGLT2 inhibitors are reshaping heart failure treatment—beyond glucose, they’re improving outcomes across the board.

Delayed Diagnosis Common in ATTR-CM, Study Finds

Rob DillardHeart Failure | June 12, 2025

Patients experienced a median 57.6-month delay from first symptoms to ATTR-CM diagnosis, study finds.

Acoramidis Cuts AFib Hospitalizations in ATTR Amyloidosis

CardioNerdsHeart Failure | June 12, 2025

MITT and safety data show acoramidis significantly lowers AFib-related events in transthyretin cardiac amyloidosis.

Expert Interviews

Cardio Care Today delivers the latest medical industry news, giving health care professionals the curated content most relevant to their fields and practices.

Get the latest medical updates and insights straight to your inbox.